Backed CSPX Core S&P 500
BCSPX
Fundamental comparison between Backed CSPX Core S&P 500 and Injective
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Backed CSPX Core S&P 500
Injective
Detailed Comparison
| Metric | Backed CSPX Core S&P 500 | Injective |
|---|---|---|
| Price | $791.98 | $4.90 |
| Market Cap | $29.20M | $489.86M |
| 24h Volume | 0 | 61.8M |
| Rank | #— | #— |
| Circulating Supply | 36.9K | 100M |
| ATH | $806.60 | $52.62 |
Backed CSPX Core S&P 500 vs Injective — Analysis
Backed CSPX Core S&P 500 and Injective are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
With a Value Score of 41.7, Backed CSPX Core S&P 500 is currently rated as "fair value", while Injective scores 70.7 and is rated "undervalued". This means our algorithm considers Injective the fundamentally stronger investment — with a significant gap of 29 points.
Market Cap & Risk
Injective has a 17x larger market capitalization than Backed CSPX Core S&P 500. A larger market cap typically means less volatility but also less growth potential. Backed CSPX Core S&P 500 may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, Backed CSPX Core S&P 500 moved -1.40%, while Injective changed 4.00%. Looking at the 7-day window, Backed CSPX Core S&P 500 is at -1.60% and Injective at -9.10%.
Distance from All-Time High
Backed CSPX Core S&P 500 currently trades at 98% of its all-time high ($806.60), while Injective sits at 9% of its ATH ($52.62). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Injective (Score: 70.7) currently has a stronger investment case than Backed CSPX Core S&P 500 (Score: 41.7). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.
